Source: Eur Respir J, 50 (6) 1700919; 10.1183/13993003.00919-2017
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Kevin Lamote, Matthijs Vynck, Olivier Thas, Joris Van Cleemput, Kristiaan Nackaerts, Jan P. van Meerbeeck. Exhaled breath to screen for malignant pleural mesothelioma: a validation study. Eur Respir J, 50 (6) 1700919; 10.1183/13993003.00919-2017

Member's Comments

No comment yet.

Related content which might interest you: Exhaled breath analysis allows exclusive screening for malignant pleural mesothelioma. Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Chemical characterization of exhaled breath to discriminate patients with malignant pleural mesothelioma from subjects with similar professional asbestos exposure Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010 LATE-BREAKING ABSTRACT: An electronic nose distinguishes the exhaled breath of patients with pleural malignant mesothelioma from subjects with professional asbestos exposure Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006 Dermcidin identification from exhaled air for lung cancer diagnosis Source: Eur Respir J 2010; 35: 1182-1185 Year: 2010 Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients. Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021 3p microsatellite evaluation in NSCLC exhaled breath condensate: validation study Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007 Drug repurposing in malignant pleural mesothelioma: a breath of fresh air? Source: Eur Respir Rev, 27 (147) 170098; 10.1183/16000617.0098-2017 Year: 2018 Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020 Year: 2021 Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009 Protein markers in the exhaled breath condensate of lung carcinoma patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Exhaled breath molecular profiling by electronic nose in non-pulmonary malignancies Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Exhaled breath condensate - a new tool for assessment of idiopathic pulmonary fibrosis? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018 Exhaled breath analysis using eNose technology in patients with sarcoidosis Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology Year: 2020 Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition? Source: Eur Respir J 2004; 24: Suppl. 48, 386s Year: 2004 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 A breath test for malignant mesothelioma using an electronic nose Source: Eur Respir J 2012; 40: 448-454 Year: 2012